The Incidence of Thromboembolic Events in Patients with Antibodies to Heparin-PF4 after Cardiac Bypass (HIT) - RTDC 5801
Source: NCBI BioProject (ID PRJNA189555)
Source: NCBI BioProject (ID PRJNA189555)
0 0
Project name: Homo sapiens
Description: The purpose of this study is to determine how often heart surgery patients who receive heparin develop an immune response (heparin-induced thrombocytopenia) that leads to clots forming in different parts of the body. These clots usually occur in the legs (deep venous thrombosis or DVT) or lungs (pulmonary embolism or PE) or cause heart attacks (myocardial infarction or MI) and strokes.
Data type: Phenotype or Genotype
Sample scope: Multiisolate
Relevance: Medical
Organization: Duke University